An experimental gingivitis study to evaluate the clinical effects of a stannous fluoride dentifrice.
OBJECTIVE
A double blind, controlled, parallel group trial utilizing the experimental gingivitis model was performed on thirty young adults to evaluate the clinical effects of a 0.45% stannous fluoride dentifrice used as a slurry on dental biofilm formation and the development of gingivitis.


METHODS
Following a thorough examination and oral prophylaxis procedures, subjects were randomly assigned to apply one of the following dentifrices twice daily over a three-week period: A) dentifrice slurry without active ingredients; B) 0.45% stannous fluoride gel; and C) Colgate Total dentifrice slurry (0.30% triclosan, 0.24% sodium fluoride, 2% copolymer).


RESULTS
After three weeks, the stannous fluoride dentifrice significantly (p < 0.05) reduced gingivitis compared with the Colgate Total group by 39.7%. Gingival bleeding was also reduced relative to the Colgate Total group. This difference was statistically significant (P < 0.05). During the experimental period, the mean PII scores increased almost linearly in all three groups without yielding any statistically significant differences.


CONCLUSIONS
The results of this clinical trial demonstrated that, over a three-week period, the application of a 0.45% SnF2 gel significantly inhibited the onset of gingivitis compared to Triclosan/sodium fluoride/copolymer (Colgate Total). However, neither stannous fluoride nor Triclosan/sodium fluoride/ copolymer (Colgate Total) possessed sufficient antimicrobial activity to suppress biofilm formation in the absence of regular oral hygiene practices.
Lang
Niklaus P
NP
University of Berne School of Dental Medicine, Berne, Switzerland. nplang@dial.eunet.ch
Anton
Elena
E
Gabriel
Yvonne
Y
Salvi
Giovanni E
GE
Pjetursson
Bjarni E
BE
Winston
J Leslie
JL
He
Tao
T
D000328:Adult; D045424:Complex Mixtures / Q000627:therapeutic use; D003773:Dental Plaque / Q000517:prevention & control*; D003774:Dental Plaque Index; D003802:Dentifrices / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D005891:Gingivitis / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010512:Periodontal Index; D012824:Silicic Acid; D014002:Tin Fluorides / Q000627:therapeutic use*; D014100:Toothpastes; D014260:Triclosan / Q000627:therapeutic use
D045424:Complex Mixtures; D003802:Dentifrices; D014002:Tin Fluorides; D014100:Toothpastes; C546060:hydrated silica gel-based toothpaste; D012824:Silicic Acid; D014260:Triclosan; D005459:Fluorides